JUBLPHARMA — Jubilant Pharmova Share News
0.000.00%
- IN₹152.72bn
- IN₹174.03bn
- IN₹82.80bn
India's Jubilant Pharmova posts surge in profit on demand for radiopharma medicines
Brief: Jubilant Pharmova Dividend 5 Rupees Per Share
India's Jubilant Pharmova hits 3-week high on strong Q4 results
Brief: Jubilant Pharmova Says Jubilant Biosys Subscribes To 80% Equity Capital In JASMIN
India's Jubilant Pharmova gains as US FDA closes inspection without urging action
Brief: Jubilant Pharmova's Unit Cadista Facility Receives EIR With VAI Status From USFDA
Brief: Jubilant Pharmova Q3 Consol Net Profit 1.01 Billion Rupees
India's Jubilant Pharmova posts 51% jump in Q3 profit on strong demand
Brief: Jubilant Pharmova Says Unit Voluntary Prepays $25 Mln Term Loan
Brief: IBA Sells Five Cyclone Kiube To Jubilant Radiopharma In U.S.
India's Jubilant Pharmova posts bigger Q2 profit on strong demand
Brief: Jubilant Pharmova Q2 Consol Net Profit 1.03 Bln Rupees
Brief: Jubilant Pharmova Says Unit’S Rectification Application Led To Deletion Of 381.3 Mln Rupees Tax Demand
Brief: Jubilant Pharmova Says JBIRSPL To Acquire 80% Stake In Jasmin For Upto 4.4 Mln Euro
Brief: Jubilant Pharmova Says USFDA Completes Audit Of Allergy Immunotherapy Facility, Spokane
India's Jubilant Pharmova rises as US FDA inspection yields no action
Brief: Jubilant Pharmova Says USFDA Inspection Classification Of Unit's Facility As Voluntary Action Indicated
India's Jubilant Pharmova hits 3-year high as unit announces investment in French firm
Brief: Jubilant Pharmova Says Unit Signed, Issued "Put Option Offer" To Pierre Fabre Laboratories